Mainstream

Takeda Pharmaceutical Non-GAAP EPS of ¥151.00, revenue of ¥1106.7B; reaffirms FY outlook

Takeda Pharmaceutical Non-GAAP EPS of ¥151.00, revenue of ¥1106.7B; reaffirms FY outlook

Post Contenttak, tkphfRead More

You might also be interested in reading Kraken Launches Crypto Services Across 30 EEA Countries Under MiCA License.

July 30, 2025
In Mainstream